Ethoxycarbonyl Group

Ethoxycarbonyl Group

SCHEMBL27474221

CCOC=O.O=C(O)CCCCn1ccc2c(Cl)cccc21

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 2/20 0.42
▸ S1PR1 P21453 2/20 0.41
▸ NOTUM Q6P988 1/20 0.40
▸ FABP4 P15090 1/20 0.40
▸ FABP5 Q01469 1/20 0.40
▸ ADRA1D P25100 2/20 0.39
▸ KRAS P01116 1/20 0.39
▸ TERT O14746 2/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ CNR2 P34972 3/20 0.38
▸ CNR1 P21554 3/20 0.38
▸ CCNT1 O60563 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CDK9 P50750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethoxycarbonyl Group SCHEMBL27474750 0.89 CNR1 (0.48) MCL1NOTUMCNR2CNR1
Ethoxycarbonyl Group SCHEMBL27528310 0.76 NOTUM (0.38) NOTUMKRAS
SCHEMBL27474220 0.70 MCL1 (0.43) MCL1S1PR1FABP4FABP5ADRA1D
SCHEMBL27587633 0.69 HTR2C (0.56) MCL1S1PR1FABP4FABP5TERT
Ethoxycarbonyl Group SCHEMBL27490855 0.69 CREBBP (0.44) MCL1FABP4CNR1
SCHEMBL7947029 0.68 FABP4 (0.49) FABP4FABP5CNR2
SCHEMBL418623 0.68 STAT3 (0.50) FABP4FABP5TERT
SCHEMBL13668164 0.67 CDK4 (0.41) MCL1NOTUMADRA1DKRASADRA1A
SCHEMBL13311382 0.67 NOTUM (0.50) NOTUMKRASCNR2CNR1
SCHEMBL1269116 0.66 CDK4 (0.71) FABP4FABP5TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1161334-A Novel substd. guanidine derivs., process for prodn. thereof, and pharmaceutical uses thereof SUMITOMO PHARMA (JP) 1997-10-08 — — CN disclosed
Send feedback